Heidi Elizabeth Franklin, MS CCC SLP | |
1104 Columbus Cir, Andrews Afb, MD 20762-5401 | |
(770) 361-5938 | |
(301) 599-0859 |
Full Name | Heidi Elizabeth Franklin |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 1104 Columbus Cir, Andrews Afb, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023283033 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 05514 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Heidi Elizabeth Franklin, MS CCC SLP 1104 Columbus Cir, Andrews Afb, MD 20762-5401 Ph: (770) 361-5938 | Heidi Elizabeth Franklin, MS CCC SLP 1104 Columbus Cir, Andrews Afb, MD 20762-5401 Ph: (770) 361-5938 |
News Archive
The SARS-CoV-2 B.1.1.7 variant, also called the UK variant, was identified in London as well as in Southeast and East of England in December 2020. Since its emergence, the UK variant has undergone several mutations that have been said to have altered its infectivity and transmissibility in the community. The B.1.1.7 variant is defined by 17 mutations, several of which are located in the SARS-CoV-2 spike protein that mediates viral attachment and entry into human cells.
Routine angiography and revascularization procedures, if indicated, appear to offer better quality of life than conservative medical treatment for patients with chest pain and evidence of coronary artery disease, according to a new study (PDF file) in the Jan. 18, 2005 issue of the Journal of the American College of Cardiology.
A team of researchers from the University of Southampton, the University of Bath and King's College London, have provided compelling evidence of the impact of adversity in childhood on neuropsychological functioning in adulthood.
Millions of people are taking herbs and other plant-based dietary supplements to improve their health, but they have precious little information on the actual effectiveness or potential ill effects of these products. That's the topic of an article in the current issue of Chemical & Engineering News weekly newsmagazine.
› Verified 8 days ago